Lifecore Biomedical (LFCR) Short Interest Ratio & Short Volume → 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad) Free LFCR Stock Alerts $5.87 +0.10 (+1.73%) (As of 05/17/2024 06:55 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Lifecore Biomedical Short Interest DataCurrent Short Volume1,980,000 sharesPrevious Short Volume1,890,000 sharesChange Vs. Previous Month+4.76%Dollar Volume Sold Short$12.71 millionShort Interest Ratio / Days to Cover9.9Last Record DateApril 30, 2024Outstanding Shares30,320,000 sharesFloat Size30,000,000 sharesShort Percent of Float6.60%Today's Trading Volume215,900 sharesAverage Trading Volume183,128 sharesToday's Volume Vs. Average118% Short Selling Lifecore Biomedical ? Sign up to receive the latest short interest report for Lifecore Biomedical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLFCR Short Interest Over TimeLFCR Days to Cover Over TimeLFCR Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Lifecore Biomedical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,980,000 shares $12.71 million +4.8%6.6%9.9 $6.42 4/15/20241,890,000 shares $11.81 million +5.6%6.3%9.5 $6.25 3/31/20241,790,000 shares $9.50 million +1.7%6.0%8.7 $5.31 3/15/20241,760,000 shares $12.99 million +1.7%5.9%9.4 $7.38 2/29/20241,730,000 shares $14.45 million +0.6%5.9%12.8 $8.35 2/15/20241,720,000 shares $14.12 million +6.2%5.9%12 $8.21 Get the Latest News and Ratings for LFCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,620,000 shares $10.58 million -2.4%5.5%11.4 $6.53 1/15/20241,660,000 shares $11.40 million +7.8%5.6%11.4 $6.87 12/31/20231,540,000 shares $9.53 million -9.4%5.2%9.7 $6.19 12/15/20231,700,000 shares $9.95 million +4.3%5.7%10.4 $5.85 11/30/20231,630,000 shares $11.69 million -11.9%5.5%9.8 $7.17 11/15/20231,850,000 shares $14.25 million +2.8%6.2%9.8 $7.70 10/31/20231,800,000 shares $12.64 million -5.8%6.1%8.1 $7.02 10/15/20231,910,000 shares $13.58 million +6.7%6.4%8.1 $7.11 9/30/20231,790,000 shares $13.51 million -11.0%6.0%7 $7.55 9/15/20232,010,000 shares $16.18 million +11.7%6.8%7.5 $8.05 8/31/20231,800,000 shares $14.40 million +6.5%6.1%4.9 $8.00 8/15/20231,690,000 shares $16.19 million +0.6%5.7%2.6 $9.58 7/31/20231,680,000 shares $17.57 million +0.6%5.7%2.6 $10.46 7/15/20231,670,000 shares $16.47 million +3.1%5.6%2.7 $9.86 6/30/20231,620,000 shares $15.67 million -36.0%5.5%2.6 $9.67 6/15/20232,530,000 shares $21.63 million +4.6%8.5%3.9 $8.55 5/31/20232,420,000 shares $19.82 million +51.3%8.2%2 $8.19 5/15/20231,600,000 shares $6.85 million No Change5.4%1.4 $4.28 LFCR Short Interest - Frequently Asked Questions What is Lifecore Biomedical's current short interest? Short interest is the volume of Lifecore Biomedical shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,980,000 shares of LFCR short. 6.60% of Lifecore Biomedical's shares are currently sold short. Learn More on Lifecore Biomedical's current short interest. What is a good short interest ratio for Lifecore Biomedical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LFCR shares currently have a short interest ratio of 10.0. Learn More on Lifecore Biomedical's short interest ratio. What is a good short interest percentage for Lifecore Biomedical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.60% of Lifecore Biomedical's floating shares are currently sold short. Is Lifecore Biomedical's short interest increasing or decreasing? Lifecore Biomedical saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,980,000 shares, an increase of 4.8% from the previous total of 1,890,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lifecore Biomedical's float size? Lifecore Biomedical currently has issued a total of 30,320,000 shares. Some of Lifecore Biomedical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lifecore Biomedical currently has a public float of 30,000,000 shares. How does Lifecore Biomedical's short interest compare to its competitors? 6.60% of Lifecore Biomedical's shares are currently sold short. Here is how the short interest of companies compare to Lifecore Biomedical: Acrivon Therapeutics, Inc. (5.22%), Organigram Holdings Inc. (5.87%), Inventiva S.A. (0.13%), Atossa Therapeutics, Inc. (9.10%), Incannex Healthcare Inc. (0.48%), Galectin Therapeutics Inc. (7.35%), Greenwich LifeSciences, Inc. (3.24%), Alimera Sciences, Inc. (0.23%), Zevra Therapeutics, Inc. (6.15%), Rigel Pharmaceuticals, Inc. (3.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Lifecore Biomedical stock? Short selling LFCR is an investing strategy that aims to generate trading profit from Lifecore Biomedical as its price is falling. LFCR shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lifecore Biomedical? A short squeeze for Lifecore Biomedical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LFCR, which in turn drives the price of the stock up even further. How often is Lifecore Biomedical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LFCR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ACRV Short Interest OGI Short Interest IVA Short Interest ATOS Short Interest IXHL Short Interest GALT Short Interest GLSI Short Interest ALIM Short Interest ZVRA Short Interest RIGL Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LFCR) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldUrgent Nvidia WarningAltimetryDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders